FDA Bans Imports from India's Polydrug Labs

Source: Reuters

Sep 15, 2015

The U.S. FDA has banned imports from Mumbai-based Polydrug Laboratories' Ambernath manufacturing plant, citing GMP concerns.

The FDA import alert comes months after Canada and Europe banned the same site for violations that included data integrity issues and a failure to record customer complaints.

Polydrug Manufactures anti-hypertension and anti-fungal meds, as well as muscle relaxants, exporting to more than 70 countries across Europe, North America and Asia.

Read the Reuters press release

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments